ABBIE Gene Editing Platform

About SOHM

SOHM Inc. is a vertically integrated biopharmaceutical company with a foundation in generic drugs and nutraceuticals, now expanding into advanced biotechnology. Founded in 2003 and headquartered in Chino, California, the company leverages global manufacturing partnerships and a proprietary gene editing platform named ABBIE to pursue a dual strategy of commercial product sales and R&D for novel therapies. Its business model spans from revenue-generating generic and over-the-counter products to early-stage research in gene editing, aiming to create a pipeline that addresses both everyday wellness and incurable diseases.

Therapeutic Areas